Literature DB >> 33600678

Advances in imaging acute ischemic stroke: evaluation before thrombectomy.

Guangchen He1, Liming Wei1, Haitao Lu1, Yuehua Li1, Yuwu Zhao2, Yueqi Zhu1.   

Abstract

Recent advances in neuroimaging have demonstrated significant assessment benefits and appropriate triage of patients based on specific clinical and radiological features in the acute stroke setting. Endovascular thrombectomy is arguably the most important aspect of acute stroke management with an extended time window. Imaging-based physiological information may potentially shift the treatment paradigm from a rigid time-based model to a more flexible and individualized, tissue-based approach, increasing the proportion of patients amenable to treatment. Various imaging modalities are routinely used in the diagnosis and management of acute ischemic stroke, including multimodal computed tomography (CT) and magnetic resonance imaging (MRI). Therefore, these imaging methods should provide information beyond the presence or absence of intracranial hemorrhage as well as the presence and extent of the ischemic core, collateral circulation and penumbra in patients with neurological symptoms. Target mismatch may optimize selection of patients with late or unknown symptom onset who would potentially be eligible for revascularization therapy. The purpose of this study was to provide a comprehensive review of the current evidence about efficacy and theoretical basis of present imaging modalities, and explores future directions for imaging in the management of acute ischemic stroke.
© 2021 Walter de Gruyter GmbH, Berlin/Boston.

Entities:  

Keywords:  acute ischemic stroke; imaging; ischemic core; mismatch; penumbra; thrombectomy

Year:  2021        PMID: 33600678     DOI: 10.1515/revneuro-2020-0061

Source DB:  PubMed          Journal:  Rev Neurosci        ISSN: 0334-1763            Impact factor:   4.353


  1 in total

1.  A meta-analysis of intravenous thrombolysis versus bridging therapy for ischemic stroke.

Authors:  Raoqiong Wang; Shuangyang Li; Linyao Hao; Zhichuan Wang; Zhengxin Ge; Sijin Yang
Journal:  Medicine (Baltimore)       Date:  2022-09-30       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.